Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,571 Blood Cancer
clinical trials

Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
National Jewish Health-Northern Hematology Oncology
mi
from
Thornton, CO
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Cancer Center Worthington
mi
from
Worthington, MN
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Wellspan Health - York Cancer Center
mi
from
York, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner High Grove
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Indu and Raj Soin Medical Center
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Elizabeth Boardman Hospital
mi
from
Boardman, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Dayton Physician LLC-Miami Valley Hospital North
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
The Women's Imaging Center
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada-Horizon Ridge
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at Oakey
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
OhioHealth Mansfield Hospital
mi
from
Mansfield, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Charles Health System-Redmond
mi
from
Redmond, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Bhadresh Nayak MD PC-Sterling Heights
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Ascension Saint Joseph Hospital
mi
from
Tawas City, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Thief River Falls Medical Center
mi
from
Thief River Falls, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Professional Building
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Central Care Cancer Center - Bolivar
mi
from
Bolivar, MO
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab for Pediatric Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab for Pediatric Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab for Pediatric Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Calgary,
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Seoul National University Hospital
mi
from
Seoul,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Status: Upcoming, Phase II
Updated: 12/31/1969
University of Iowa Stead Family Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
UZ Gent
mi
from
Gent,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
Status: Upcoming, Phase I
Updated: 12/31/1969
The University of Michigan Rogel Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Guadecitabine Extension Study
Status: Upcoming, Phase II
Updated: 12/31/1969
Medizinische Universität Graz
mi
from
Graz,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
American Institute of Research (AIR)
mi
from
Whittier, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Research Site
mi
from
Adelaide,
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Watertown, SD
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
Status: Upcoming, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Status: Upcoming, Phase I
Updated: 12/31/1969
Rcca Md, Llc
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
Status: Upcoming, Phase I
Updated: 12/31/1969
Houston Methodist Hosptial
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
The Oncology Institute of Hope and Innovation
mi
from
Tucson, AZ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Status: Upcoming, Phase I, II
Updated: 7/25/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
Status: Upcoming, Phase
Updated: 12/31/1969
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
Status: Upcoming, Phase I
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant
Status: Upcoming
Updated: 12/31/1969
Penn State Cancer Institute
mi
from
Hershey, PA
Click here to add this to my saved trials
1 … 108 109 110 111 112 113 114 115 116